Delivery Order SPE2DB20D3111-SPE2DB25FA8XK
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (quantity 90) with a ceiling value of $1,558.90. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performed the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,357.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 75 mg tablets in quantities of 90 units. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,035.92 to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (90-count) on September 16, 2025, with completion anticipated by September 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of a generic antihypertensive medication to support federal healthcare operations. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $83,200 to Amerisourcebergen Drug Corporation to supply 150mg Irbesartan tablets. As the prime contractor, Amerisourcebergen will deliver 90 count bottles of the hypertension medication to a facility in Conshohocken, Pennsylvania between July 12-13, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No set aside provisions or subcontractors were...
- The Defense Logistics Agency awarded a delivery order valued at $362,880 to Amerisourcebergen Drug Corporation for the provision of 150 mg Irbesartan tablets. The firm fixed price order calls for the delivery of 90 count bottles of the hypertension medication to a facility in Conshohocken, Pennsylvania, with performance required between July 24-25, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets. The contract has a period of performance through November 12, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.84 firm fixed-price delivery order contract is for the supply of Irbesartan 300 mg tablets. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- The Defense Logistics Agency awarded a $259,200 delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg Irbesartan tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 90 count bottles of the hypertension medication to a facility in Conshohocken, Pennsylvania by July 25, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 Defense Logistics Agency supplier, Amerisourcebergen will utilize its established distribution...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8XKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime supplier to the Defense Health Agency and other military healthcare systems through its $999,999,999.00 indefinite delivery vehicle with DLA Troop Support Medical, which extends through December 2026. This delivery order for the hypertension medication Irbesartan exemplifies the company's role in supplying a comprehensive range of pharmaceutical products, including brand-name and generic medications, to support military and federal healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/14/25 |